Dr. Michael Daneshvar is a fellowship trained Urologic Oncologist from the National Cancer Institute (NCI)/National Institutes of Health (NIH). He specializes in both robotic and open surgery for the treatment of bladder, kidney, prostate, penile, testis, and adrenal cancer. His research interests include hereditary diseases and genomic alterations in genitourinary cancer. In addition, he is well published and has an interest in novel imaging techniques (artificial intelligence, PSMA), focal therapy and ablation of prostate cancer.
Masters: Biomedical Sciences, Rosalind Franklin University of Medicine and Science
Medical School: With a Distinction in Research (MDDR), Chicago Medical School, Rosalind Franklin University of Medicine and Science
Internship & Residency: SUNY Upstate Medical University
Fellowship: Society of Urologic Oncology Fellow, Urologic Oncology Branch, National Cancer Institute/National Institutes of Health (NCI/NIH)